002788 鹭燕医药
已收盘 10-31 15:00:00
资讯
新帖
简况
鹭燕医药(002788)2025年三季报简析:增收不增利
证券之星 · 10-27
鹭燕医药(002788)2025年三季报简析:增收不增利
股市必读:鹭燕医药(002788)股东户数2.27万户,较上期减少3.01%
证券之星 · 10-26
股市必读:鹭燕医药(002788)股东户数2.27万户,较上期减少3.01%
鹭燕医药(002788.SZ)发布前三季度业绩,归母净利润2.2亿元,同比下降14.64%
智通财经网 · 10-26
鹭燕医药(002788.SZ)发布前三季度业绩,归母净利润2.2亿元,同比下降14.64%
股市必读:鹭燕医药(002788)10月14日董秘有最新回复
证券之星 · 10-14
股市必读:鹭燕医药(002788)10月14日董秘有最新回复
鹭燕医药(002788.SZ)子公司拟设立2家负责酒店运营管理的全资子公司
智通财经 · 09-25
鹭燕医药(002788.SZ)子公司拟设立2家负责酒店运营管理的全资子公司
鹭燕医药:公司与七匹狼无其他关联关系
证券之星 · 08-27
鹭燕医药:公司与七匹狼无其他关联关系
鹭燕医药(002788)2025年中报简析:增收不增利
证券之星 · 08-26
鹭燕医药(002788)2025年中报简析:增收不增利
鹭燕医药:2025年上半年净利润1.55亿元,同比下降18.83%
金融界 · 08-25
鹭燕医药:2025年上半年净利润1.55亿元,同比下降18.83%
鹭燕医药新注册《中药饮片制造执行系统V1.0》项目的软件著作权
证券之星 · 07-15
鹭燕医药新注册《中药饮片制造执行系统V1.0》项目的软件著作权
鹭燕医药新注册《供应商询价系统V1.0》项目的软件著作权
证券之星 · 06-19
鹭燕医药新注册《供应商询价系统V1.0》项目的软件著作权
鹭燕医药:医药零售是公司业务重要组成部分
证券之星 · 05-28
鹭燕医药:医药零售是公司业务重要组成部分
鹭燕医药:医保经办机构与企业签订协议明确回款时限缩短结算周期
证券之星 · 03-11
鹭燕医药:医保经办机构与企业签订协议明确回款时限缩短结算周期
鹭燕医药:始终坚持专注主业,合规经营,行稳致远,实实在在为投资者创造价值
证券之星 · 02-25
鹭燕医药:始终坚持专注主业,合规经营,行稳致远,实实在在为投资者创造价值
鹭燕医药:公司现代中医药产业园项目目前正在进行内部装修及设备安装、调试中
证券之星 · 02-14
鹭燕医药:公司现代中医药产业园项目目前正在进行内部装修及设备安装、调试中
鹭燕医药:公司下属亳州市中药饮片厂产品主要为中药饮片生产、销售等
证券之星 · 02-12
鹭燕医药:公司下属亳州市中药饮片厂产品主要为中药饮片生产、销售等
鹭燕医药:公司不同门店经营品类可能存在差异敬请咨询具体门店
证券之星 · 02-11
鹭燕医药:公司不同门店经营品类可能存在差异敬请咨询具体门店
鹭燕医药:公司将“为人类健康事业做贡献”作为企业使命
证券之星 · 01-13
鹭燕医药:公司将“为人类健康事业做贡献”作为企业使命
鹭燕医药:蓝马资本、太空融基金等多家机构于12月18日调研我司
证券之星 · 2024-12-19
鹭燕医药:蓝马资本、太空融基金等多家机构于12月18日调研我司
鹭燕医药:12月5日高管朱明国减持股份合计10万股
证券之星 · 2024-12-06
鹭燕医药:12月5日高管朱明国减持股份合计10万股
鹭燕医药:12月3日高管朱明国减持股份合计10万股
证券之星 · 2024-12-04
鹭燕医药:12月3日高管朱明国减持股份合计10万股
加载更多
公司概况
公司名称:
鹭燕医药股份有限公司
所属行业:
批发业
上市日期:
2016-02-18
主营业务:
鹭燕医药股份有限公司的主营业务是医药分销与零售业务。公司的主要产品是药品、中药饮片、医疗器械等分销及医药零售连锁。公司自成立以来,不断提升品牌价值,致力于为客户及上游供应商提供优质的服务,得到客户和行业的广泛认同,在行业中享有较高的商誉和知名度,“鹭燕”和“燕来福”获得厦门市著名商标、福建省著名商标等荣誉。
发行价格:
18.65
{"stockData":{"symbol":"002788","market":"SZ","secType":"STK","nameCN":"鹭燕医药","latestPrice":8.54,"timestamp":1761894192000,"preClose":8.45,"halted":0,"volume":5696976,"delay":0,"changeRate":0.0107,"floatShares":382000000,"shares":389000000,"eps":0.7927,"marketStatus":"已收盘","change":0.09,"latestTime":"10-31 15:00:00","open":8.45,"high":8.56,"low":8.4,"amount":48435200,"amplitude":0.0189,"askPrice":8.54,"askSize":89,"bidPrice":8.53,"bidSize":252,"shortable":0,"etf":0,"ttmEps":0.7927,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":5,"adr":0,"adjPreClose":8.45,"symbolType":"stock","openAndCloseTimeList":[[1761874200000,1761881400000],[1761886800000,1761894000000]],"highLimit":9.3,"lowLimit":7.6,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":388516736,"isCdr":false,"pbRate":1.01,"roa":"--","peRate":10.773306,"roe":"6.71%","epsLYR":0.89,"committee":-0.21675,"marketValue":3318000000,"turnoverRate":0.0149,"status":0,"floatMarketCap":3261000000},"requestUrl":"/m/hq/s/002788","defaultTab":"news","newsList":[{"id":"2578749336","title":"鹭燕医药(002788)2025年三季报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2578749336","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578749336?lang=zh_cn&edition=full","pubTime":"2025-10-28 06:06","pubTimestamp":1761602784,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期鹭燕医药发布2025年三季报。根据财报显示,鹭燕医药增收不增利。截至本报告期末,公司营业总收入158.55亿元,同比上升2.87%,归母净利润2.2亿元,同比下降14.64%。按单季度数据看,第三季度营业总收入54.55亿元,同比上升6.81%,第三季度归母净利润6513.66万元,同比下降2.74%。本次财报公布的各项数据指标表现一般。去年的净利率为1.7%,算上全部成本后,公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800006494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"gpt_icon":0},{"id":"2578066355","title":"股市必读:鹭燕医药(002788)股东户数2.27万户,较上期减少3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578066355","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578066355?lang=zh_cn&edition=full","pubTime":"2025-10-27 06:41","pubTimestamp":1761518470,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,鹭燕医药报收于8.43元,下跌0.47%,换手率1.03%,成交量3.95万手,成交额3337.82万元。当日关注点来自交易信息汇总:10月24日主力资金净流入21.51万元,呈现小幅吸筹态势。股本股东变化股东户数变动截至2025年9月30日,鹭燕医药股东户数为2.27万户,较6月30日减少706.0户,降幅为3.01%;户均持股数量由上期的1.66万股增至1.71万股,户均持股市值为13.8万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2578636644","title":"鹭燕医药(002788.SZ)发布前三季度业绩,归母净利润2.2亿元,同比下降14.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578636644","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578636644?lang=zh_cn&edition=full","pubTime":"2025-10-26 16:45","pubTimestamp":1761468314,"startTime":"0","endTime":"0","summary":"鹭燕医药(002788.SZ)发布2025年三季度报告,前三季度,公司实现营业收入...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/astock/20.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/20.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002788"],"gpt_icon":0},{"id":"2575224497","title":"股市必读:鹭燕医药(002788)10月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2575224497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575224497?lang=zh_cn&edition=full","pubTime":"2025-10-15 03:54","pubTimestamp":1760471651,"startTime":"0","endTime":"0","summary":"截至2025年10月14日收盘,鹭燕医药报收于8.24元,上涨0.49%,换手率1.1%,成交量4.2万手,成交额3454.02万元。董秘最新回复投资者: 请问公司建的两座希尔顿酒店,是否可以向中小投资者提供优惠,散户股东去福建旅游,可以半价住希尔顿吗?当日关注点来自交易信息汇总:10月14日主力资金净流出563.98万元,散户资金净流入613.25万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500003609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"gpt_icon":0},{"id":"2570018432","title":"鹭燕医药(002788.SZ)子公司拟设立2家负责酒店运营管理的全资子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2570018432","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570018432?lang=zh_cn&edition=full","pubTime":"2025-09-25 21:19","pubTimestamp":1758806399,"startTime":"0","endTime":"0","summary":"智通财经APP讯,鹭燕医药(002788.SZ)发布公告,为打造医疗康复、养生调理等医药健康产业生态,子公司鹭燕嘉文拟依托总部项目,增加投资额约为6亿元人民币用于投资建设具有差异化竞争优势的2家酒店,并以酒店项目为依托,孵化医疗康复、健康养生、养老休闲、体育、文旅等健康领域业务,延伸健康服务价值链。为便于酒店项目后续的开发建设及管理,鹭燕嘉文拟以自有资金出资设立2家负责酒店运营管理的全资子公司酒店管理公司,同时引进国际知名酒店品牌(希尔顿)和经营团队,负责酒店的日常经营管理。2家酒店管理公司注册资本分别为人民币1,000万元和2,000万元,鹭燕嘉文持股比例均为100%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","002788"],"gpt_icon":0},{"id":"2562713774","title":"鹭燕医药:公司与七匹狼无其他关联关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2562713774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562713774?lang=zh_cn&edition=full","pubTime":"2025-08-27 16:18","pubTimestamp":1756282694,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)08月27日在投资者关系平台上答复投资者关心的问题。投资者提问:公司跟七匹狼什么关系?怎么还有七匹狼换届关联公告?鹭燕医药回复:您好,公司独立董事叶少琴女士兼任福建七匹狼实业股份有限公司独立董事,除此之外,公司与福建七匹狼实业股份有限公司无其他关联关系。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700033348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002029","BK0253","002788","BK0188","BK0250","BK0028"],"gpt_icon":0},{"id":"2562763643","title":"鹭燕医药(002788)2025年中报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2562763643","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562763643?lang=zh_cn&edition=full","pubTime":"2025-08-27 06:23","pubTimestamp":1756247011,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期鹭燕医药发布2025年中报。根据财报显示,鹭燕医药增收不增利。截至本报告期末,公司营业总收入104.0亿元,同比上升0.91%,归母净利润1.55亿元,同比下降18.83%。筹资活动产生的现金流量净额变动幅度为36.07%,原因:本期归还贷款及利息支出减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700008605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2562424636","title":"鹭燕医药:2025年上半年净利润1.55亿元,同比下降18.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562424636","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562424636?lang=zh_cn&edition=full","pubTime":"2025-08-25 19:23","pubTimestamp":1756120994,"startTime":"0","endTime":"0","summary":"鹭燕医药公告,2025年上半年营业收入104亿元,同比增长0.91%。净利润1.55亿元,同比下降18.83%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/25192352673306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002788"],"gpt_icon":0},{"id":"2551199788","title":"鹭燕医药新注册《中药饮片制造执行系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2551199788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551199788?lang=zh_cn&edition=full","pubTime":"2025-07-16 01:34","pubTimestamp":1752600849,"startTime":"0","endTime":"0","summary":"证券之星消息,近日鹭燕医药(002788)新注册了《中药饮片制造执行系统V1.0》项目的软件著作权。今年以来鹭燕医药新注册软件著作权3个。结合公司2024年年报财务数据,2024年公司在研发方面投入了584.6万元,同比增5.63%。通过天眼查大数据分析,鹭燕医药股份有限公司共对外投资了27家企业,参与招投标项目43次;财产线索方面有商标信息121条,著作权信息2条;此外企业还拥有行政许可26个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600000962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2544119307","title":"鹭燕医药新注册《供应商询价系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2544119307","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544119307?lang=zh_cn&edition=full","pubTime":"2025-06-20 01:26","pubTimestamp":1750353975,"startTime":"0","endTime":"0","summary":"证券之星消息,近日鹭燕医药(002788)新注册了《供应商询价系统V1.0》项目的软件著作权。今年以来鹭燕医药新注册软件著作权2个。结合公司2024年年报财务数据,2024年公司在研发方面投入了584.6万元,同比增5.63%。通过天眼查大数据分析,鹭燕医药股份有限公司共对外投资了27家企业,参与招投标项目43次;财产线索方面有商标信息121条,著作权信息1条;此外企业还拥有行政许可24个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000000287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2538941632","title":"鹭燕医药:医药零售是公司业务重要组成部分","url":"https://stock-news.laohu8.com/highlight/detail?id=2538941632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538941632?lang=zh_cn&edition=full","pubTime":"2025-05-28 08:55","pubTimestamp":1748393720,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)05月27日在投资者关系平台上答复投资者关心的问题。投资者提问:面对外部连锁对福建本地的持续渗透,公司对福建基本盘有何对策么?是否会持续加大布局门店,公司今年现金流还充足么鹭燕医药回复:医药零售是公司业务重要组成部分,公司将根据市场实际情况做大做强医药零售业务。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052800005843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK1515","09939","BK1161","BK1574","159938","BK0250"],"gpt_icon":0},{"id":"2518764952","title":"鹭燕医药:医保经办机构与企业签订协议明确回款时限缩短结算周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2518764952","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518764952?lang=zh_cn&edition=full","pubTime":"2025-03-11 15:12","pubTimestamp":1741677139,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好请问,公司应收账款在医保结算改革后有无短期收回的可能性呢?鹭燕医药回复:医保经办机构分别与医疗机构和供货企业签订货款结算协议,明确结算方式、责任义务以及回款的时限,能在一定程度上缩短货款结算周期。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100021036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"gpt_icon":0},{"id":"2514094052","title":"鹭燕医药:始终坚持专注主业,合规经营,行稳致远,实实在在为投资者创造价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2514094052","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514094052?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:30","pubTimestamp":1740472239,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)02月25日在投资者关系平台上答复投资者关心的问题。投资者:观察到公司累计分红金额已经快超过上市融资额,公司价值并没有获得市场认可,作为福建优秀上市公司,是否制定了一系列市值提升计划呢?鹭燕医药董秘:感谢您对公司的认可。公司以“为人类健康做贡献”为使命,以“打造现代医药百年企业”为愿景,以“诚信、务实、创新、共赢”为核心价值观,始终坚持专注主业,合规经营,行稳致远,实实在在为投资者创造价值。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022500028324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2511657612","title":"鹭燕医药:公司现代中医药产业园项目目前正在进行内部装修及设备安装、调试中","url":"https://stock-news.laohu8.com/highlight/detail?id=2511657612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511657612?lang=zh_cn&edition=full","pubTime":"2025-02-14 17:30","pubTimestamp":1739525424,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)02月14日在投资者关系平台上答复投资者关心的问题。投资者:请问贵公司的现代中医药产业园项目一期是否已经投产?鹭燕医药董秘:尊敬的投资者,你好。公司现代中医药产业园项目目前正在进行内部装修及设备安装、调试中。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021400028137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2510398507","title":"鹭燕医药:公司下属亳州市中药饮片厂产品主要为中药饮片生产、销售等","url":"https://stock-news.laohu8.com/highlight/detail?id=2510398507","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510398507?lang=zh_cn&edition=full","pubTime":"2025-02-12 09:00","pubTimestamp":1739322056,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药02月11日在投资者关系平台上答复投资者关心的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021200006766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2510156872","title":"鹭燕医药:公司不同门店经营品类可能存在差异敬请咨询具体门店","url":"https://stock-news.laohu8.com/highlight/detail?id=2510156872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510156872?lang=zh_cn&edition=full","pubTime":"2025-02-11 16:30","pubTimestamp":1739262636,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)02月11日在投资者关系平台上答复投资者关心的问题。投资者:公司门店是否可以购买二级医疗器械电子手表?比如华为watch.鹭燕医药董秘:公司全力为客户提供优质的药械产品。公司不同门店因受门店规模、核心客户群体等因素的影响,经营的品类可能存在差异,关于某一具体商品的采购敬请咨询具体门店。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021100025708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2503346757","title":"鹭燕医药:公司将“为人类健康事业做贡献”作为企业使命","url":"https://stock-news.laohu8.com/highlight/detail?id=2503346757","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503346757?lang=zh_cn&edition=full","pubTime":"2025-01-13 12:00","pubTimestamp":1736740825,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)01月13日在投资者关系平台上答复投资者关心的问题。投资者:公司的大健康战略是否包含国家大力提倡的银发经济呢鹭燕医药董秘:公司将“为人类健康事业做贡献”作为企业使命,其中也当然包括了为老年人的健康提供更好的服务。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011300013318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2492837141","title":"鹭燕医药:蓝马资本、太空融基金等多家机构于12月18日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492837141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492837141?lang=zh_cn&edition=full","pubTime":"2024-12-19 17:04","pubTimestamp":1734599081,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年12月19日鹭燕医药发布公告称蓝马资本、太空融基金、广州顺从、金时资本、世纪量子、知远投资、图灵投资、湖北盛世、内蒙古博汇、恒天成基金于2024年12月18日调研我司。另,款方式和账期长短影响企业的资金周转效率,进而影响毛利率。没有出现未公开重大信息泄露等情况。鹭燕医药主营业务:药品、中药饮片、医疗器械、疫苗等分销及医药零售连锁。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121900028181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0},{"id":"2489223867","title":"鹭燕医药:12月5日高管朱明国减持股份合计10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489223867","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489223867?lang=zh_cn&edition=full","pubTime":"2024-12-06 21:31","pubTimestamp":1733491883,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月6日市场公开信息、上市公司公告及交易所披露数据整理,鹭燕医药(002788)最新董监高及相关人员股份变动情况:2024年12月5日公司高管朱明国共减持公司股份10.0万股,占公司总股本为0.0257%。变动期间公司股价上涨0.34%,12月5日当日收盘报8.76元。鹭燕医药近半年内的董监高及核心技术人员增减持详情如下:鹭燕医药的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600043826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"gpt_icon":0},{"id":"2488408193","title":"鹭燕医药:12月3日高管朱明国减持股份合计10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488408193","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488408193?lang=zh_cn&edition=full","pubTime":"2024-12-04 21:01","pubTimestamp":1733317268,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月4日市场公开信息、上市公司公告及交易所披露数据整理,鹭燕医药(002788)最新董监高及相关人员股份变动情况:2024年12月3日公司高管朱明国共减持公司股份10.0万股,占公司总股本为0.0257%。变动期间公司股价下跌0.56%,12月3日当日收盘报8.93元。鹭燕医药近半年内的董监高及核心技术人员增减持详情如下:鹭燕医药的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400038808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1761975590217,"stockEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0569},{"period":"3month","weight":-0.0161},{"period":"6month","weight":0.1081},{"period":"1year","weight":0.0493},{"period":"ytd","weight":0.0838}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0185},{"period":"3month","weight":0.1109},{"period":"6month","weight":0.2061},{"period":"1year","weight":0.2058},{"period":"ytd","weight":0.1799}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"鹭燕医药股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"22747人(较上一季度减少3.01%)","perCapita":"16784股","listingDate":"2016-02-18","address":"福建省厦门市湖里区安岭路1004号","registeredCapital":"38851万元","survey":" 鹭燕医药股份有限公司的主营业务是医药分销与零售业务。公司的主要产品是药品、中药饮片、医疗器械等分销及医药零售连锁。公司自成立以来,不断提升品牌价值,致力于为客户及上游供应商提供优质的服务,得到客户和行业的广泛认同,在行业中享有较高的商誉和知名度,“鹭燕”和“燕来福”获得厦门市著名商标、福建省著名商标等荣誉。","listedPrice":18.65},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹭燕医药(002788)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹭燕医药(002788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹭燕医药,002788,鹭燕医药股票,鹭燕医药股票老虎,鹭燕医药股票老虎国际,鹭燕医药行情,鹭燕医药股票行情,鹭燕医药股价,鹭燕医药股市,鹭燕医药股票价格,鹭燕医药股票交易,鹭燕医药股票购买,鹭燕医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹭燕医药(002788)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹭燕医药(002788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}